Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients
This study has been completed.
Sponsor:
King Abdulaziz Medical City
Collaborators:
Riyadh Military Hospital
King Faisal Specialist Hospital & Research Center
Information provided by (Responsible Party):
Faisal M Sanai, King Abdulaziz Medical City
ClinicalTrials.gov Identifier:
NCT00881582
First received: April 14, 2009
Last updated: September 13, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2011 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |